InterCure Ltd.

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 07:55:00 15/05/2024 pm IST			5-day change	1st Jan Change
1,131 ^ILa	-4.80%		-8.86%	+144.22%

01/05	InterCure Ltd. Provides Revenue Guidance for the Full Year 2024	CI
01/05	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

InterCure Ltd. announced that it has received ILS 1.5 million in funding

December 04, 2016

On December 4, 2016, InterCure Ltd. (TASE:INCR) closed the transaction.

Latest news about InterCure Ltd.

InterCure Ltd. Provides Revenue Guidance for the Full Year 2024	01/05	CI
InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/05	CI
InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023	01/04	CI
InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months	22/03	CI
InterCure Ltd. Announces Resignation of Rami Levy as Chief of Operations	14/02	CI
InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million.	31/01	CI
InterCure Ltd.(TASE:INCR) dropped from S&P Global BMI Index	18/23/18	CI
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	01/23/01	CI
Intercure to Delist Its Shares From the Toronto Stock Exchange	11/23/11	MT
InterCure Provides Update About Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger	12/23/12	MT
Transcript : InterCure Ltd., 2022 Earnings Call, Apr 04, 2023	05/23/05
InterCure Ltd. entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd.	16/22/16	CI
InterCure to Launch Trading on Nasdaq Wednesday	01/21/01	MT
InterCure Ltd. Announces Earnings Results for the Second Quarter Ended June 30, 2021	17/21/17	CI
InterCure Provided Update on Its NASDAQ Listing	12/21/12	MT
InterCure Ltd signed a Letter of Intent to acquire Cann Pharmaceutical Ltd. for $35 million.	05/21/05	CI
InterCure : Israel's Canndoc signs cannabis import-export deal with Tilray	02/20/02	RE
Regenera Pharma Ltd. announced that it expects to receive funding from InterCure Ltd. and other investors	18/16/18	CI
InterCure Ltd. announced that it has received ILS 1.5 million in funding	04/16/04	CI
InterCure Ltd. announced that it expects to receive ILS 1.5 million in funding	28/16/28	CI
InterCure Ltd. completed the acquisition of additional 7.43% stake in Regenera Pharma Ltd. from Bamot Investments Ltd.	27/16/27	CI
InterCure Ltd. signed an agreement to acquire additional 7.43% stake in Regenera Pharma Ltd. from Bamot Investments Ltd. for ILS 3 million.	11/16/11	CI
Novellusdx Ltd. announced that it has received $12.5 million in funding from Pontifax Ltd., InterCure Ltd., OrbiMed Advisors, L.L.C.	22/16/22	CI

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Sector

Healthcare Facilities & Services

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Farming

	1st Jan change	Capi.
INTERCURE LTD.	+144.22%	14Cr
CRUCIAL INNOVATIONS CORP.	-.--%	34Cr
ASCEND WELLNESS HOLDINGS, INC.	+32.99%	27Cr
AYR WELLNESS INC.	+47.33%	29Cr
ORGANIGRAM HOLDINGS INC.	+51.74%	20Cr
JUSHI HOLDINGS INC.	+53.54%	14Cr
THE CANNABIST COMPANY HOLDINGS INC.	-39.55%	33Cr
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	12Cr
4FRONT VENTURES CORP.	+19.23%	10Cr
VEXT SCIENCE, INC.	+10.34%	5.77Cr

Medical Farming

InterCure Ltd.

Equities

INCR

IL0011063760

Healthcare Facilities & Services

InterCure Ltd. announced that it has received ILS 1.5 million in funding

Latest news about InterCure Ltd.

Chart InterCure Ltd.

Company Profile

Income Statement Evolution

Quarterly revenue - Rate of surprise

Sector Medical Farming